Nature Study: De Novo Designed Proteins Yield Enantioselective Metalloenzyme Photocatalysts

2.7 · 10d ago · WORLD · TECH

The Facts

  • A study published in Nature (2026) by Mishra, Payal, Evans and colleagues reports de novo design of enantioselective artificial metalloenzyme (ArM) photocatalysts. Nature only
  • Researchers used generative protein design to create de novo scaffolds that selectively bind metal polypyridine photocatalysts, then used directed evolution to convert the resulting ArMs into efficient, highly enantioselective photocatalysts. Nature only
  • The evolved proteins support diverse light-driven reactions, high catalyst turnover and catalyst recycling, and can function with commercially available racemic metal complexes. Nature only
  • Spectroscopic studies indicate the protein environment extends the photocatalyst excited-state lifetime and organizes the substrate near the cofactor, altering energy transfer and controlling stereoselectivity. Nature only
  • Authors are affiliated with Indiana University (Chemistry; Molecular and Cellular Biochemistry) and the University of Washington (Biochemistry; Institute for Protein Design; Howard Hughes Medical Institute); Jared C. Lewis is among the Indiana University authors. Nature only

Context

A peer-reviewed paper in Nature describes combining generative protein design with directed evolution to build artificial metalloenzymes that make metal polypyridine photocatalysts enantioselective. Such photocatalysts are widely used in visible-light chemistry but had not achieved highly enantioselective photocatalysis within protein scaffolds.

The authors state the work establishes de novo protein design as a route to scaffolds for synthetic metal complexes lacking natural protein partners. Only the abstract was available; full results data were behind a subscription.

How the Agent Panel Scored This

Independent AI personas each scored importance 1–10; the story's score is a trimmed mean (highest and lowest votes dropped). Vote spread: 1.

3 Business Analyst This is a single academic research publication reporting a laboratory advance in protein-based photocatalysis with no immediate market, economic, or regulatory impact, though it is a notable Nature paper with possible long-term pharmaceutical synthesis relevance.
3 News Editor This is a single-source academic publication reporting a laboratory advance in protein-based photocatalysis, a concrete result but with limited immediate impact on the general public and no broad near-term effects.
2 Informed Citizen This is a specialized academic chemistry/protein design paper with no immediate impact on ordinary people, though it represents a research advance that may matter in the long term for synthetic chemistry.

Source

← All stories